Recent research and development of Antrodia cinnamomea

Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and...

Full description

Saved in:
Bibliographic Details
Published inPharmacology & therapeutics (Oxford) Vol. 139; no. 2; pp. 124 - 156
Main Authors Lu, Mei-Chin, El-Shazly, Mohamed, Wu, Tung-Ying, Du, Ying-Chi, Chang, Tun-Tschu, Chen, Chieh-Fu, Hsu, Yu-Ming, Lai, Kuei-Hung, Chiu, Ching-Peng, Chang, Fang-Rong, Wu, Yang-Chang
Format Journal Article
LanguageEnglish
Published England 01.08.2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and to enhance liver functions. It was included in Asian folk medicine in the last few decades with remarkable results in treating inflammatory disorders, cancers, hypertension and hepatitis. This myriad of therapeutic activities encouraged several research groups to subject A. cinnamomea to intensive biological and phytochemical investigation, leading to the isolation of different classes of pharmacologically active secondary metabolites. The in vitro and in vivo biological results of the mushroom extracts and its active components revealed their potent cytotoxic, anti-inflammatory and hepatoprotective activities. The aim of this study is to review recent reports on the biological activities of A. cinnamomea extracts and its active components; quality control protocols; synthetic methodologies for the preparation of active components; developed culture techniques; phylogenetic analysis and gene cloning. This study also tackles major challenges facing future expansion of A. cinnamomea production.
AbstractList Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and to enhance liver functions. It was included in Asian folk medicine in the last few decades with remarkable results in treating inflammatory disorders, cancers, hypertension and hepatitis. This myriad of therapeutic activities encouraged several research groups to subject A. cinnamomea to intensive biological and phytochemical investigation, leading to the isolation of different classes of pharmacologically active secondary metabolites. The in vitro and in vivo biological results of the mushroom extracts and its active components revealed their potent cytotoxic, anti-inflammatory and hepatoprotective activities. The aim of this study is to review recent reports on the biological activities of A. cinnamomea extracts and its active components; quality control protocols; synthetic methodologies for the preparation of active components; developed culture techniques; phylogenetic analysis and gene cloning. This study also tackles major challenges facing future expansion of A. cinnamomea production.
Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and to enhance liver functions. It was included in Asian folk medicine in the last few decades with remarkable results in treating inflammatory disorders, cancers, hypertension and hepatitis. This myriad of therapeutic activities encouraged several research groups to subject A. cinnamomea to intensive biological and phytochemical investigation, leading to the isolation of different classes of pharmacologically active secondary metabolites. The in vitro and in vivo biological results of the mushroom extracts and its active components revealed their potent cytotoxic, anti-inflammatory and hepatoprotective activities. The aim of this study is to review recent reports on the biological activities of A. cinnamomea extracts and its active components; quality control protocols; synthetic methodologies for the preparation of active components; developed culture techniques; phylogenetic analysis and gene cloning. This study also tackles major challenges facing future expansion of A. cinnamomea production.Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory agents. Antrodia cinnamomea is a treasured Taiwanese mushroom that has been used by aboriginal tribes for centuries to treat food intoxication and to enhance liver functions. It was included in Asian folk medicine in the last few decades with remarkable results in treating inflammatory disorders, cancers, hypertension and hepatitis. This myriad of therapeutic activities encouraged several research groups to subject A. cinnamomea to intensive biological and phytochemical investigation, leading to the isolation of different classes of pharmacologically active secondary metabolites. The in vitro and in vivo biological results of the mushroom extracts and its active components revealed their potent cytotoxic, anti-inflammatory and hepatoprotective activities. The aim of this study is to review recent reports on the biological activities of A. cinnamomea extracts and its active components; quality control protocols; synthetic methodologies for the preparation of active components; developed culture techniques; phylogenetic analysis and gene cloning. This study also tackles major challenges facing future expansion of A. cinnamomea production.
Author Chang, Fang-Rong
Hsu, Yu-Ming
Lu, Mei-Chin
Chen, Chieh-Fu
Lai, Kuei-Hung
Chiu, Ching-Peng
El-Shazly, Mohamed
Du, Ying-Chi
Wu, Tung-Ying
Chang, Tun-Tschu
Wu, Yang-Chang
Author_xml – sequence: 1
  givenname: Mei-Chin
  surname: Lu
  fullname: Lu, Mei-Chin
  organization: Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Taiwan
– sequence: 2
  givenname: Mohamed
  surname: El-Shazly
  fullname: El-Shazly, Mohamed
– sequence: 3
  givenname: Tung-Ying
  surname: Wu
  fullname: Wu, Tung-Ying
– sequence: 4
  givenname: Ying-Chi
  surname: Du
  fullname: Du, Ying-Chi
– sequence: 5
  givenname: Tun-Tschu
  surname: Chang
  fullname: Chang, Tun-Tschu
– sequence: 6
  givenname: Chieh-Fu
  surname: Chen
  fullname: Chen, Chieh-Fu
– sequence: 7
  givenname: Yu-Ming
  surname: Hsu
  fullname: Hsu, Yu-Ming
– sequence: 8
  givenname: Kuei-Hung
  surname: Lai
  fullname: Lai, Kuei-Hung
– sequence: 9
  givenname: Ching-Peng
  surname: Chiu
  fullname: Chiu, Ching-Peng
– sequence: 10
  givenname: Fang-Rong
  surname: Chang
  fullname: Chang, Fang-Rong
– sequence: 11
  givenname: Yang-Chang
  surname: Wu
  fullname: Wu, Yang-Chang
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23563277$$D View this record in MEDLINE/PubMed
BookMark eNqFkEtLw0AUhQep2If-BcnSTeKdRzKZZSm-oCBIF-7CzeSGpiQzcZII_ntbrOBOOHAOnI-zOEs2c94RYxGHhAPP7g9Jv8fQjXsKmAjgMgGVAPALtuC5NvGReZ_9yXO2HIYDACgF4orNhUwzKbResOyNLLkxCjQQBruP0FVRRZ_U-r47Fb6O1m4Mvmowso1z2PmO8Jpd1tgOdHP2Fds9Puw2z_H29ells97GvVBqjFHJGnMQua41lqnKpCJ1kiHBrdVoMywNoDAlgqylhrSuUmOMFZSClit29zPbB_8x0TAWXTNYalt05Keh4FrKVGgj8v9RqQVoozN1RG_P6FR2VBV9aDoMX8XvK_IbVLVoLg
ContentType Journal Article
Copyright Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2013 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.pharmthera.2013.04.001
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList AGRICOLA
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1879-016X
EndPage 156
ExternalDocumentID 23563277
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GroupedDBID ---
--K
--M
.GJ
.~1
0R~
123
1B1
1RT
1~.
1~5
29O
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATTM
AAXKI
AAXUO
ABFNM
ABMAC
ABWVN
ABXDB
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ACRPL
ADBBV
ADEZE
ADMUD
ADNMO
AEBSH
AEIPS
AEKER
AENEX
AFFNX
AFJKZ
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AKRWK
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CGR
CS3
CUY
CVF
DU5
EBS
ECM
EFJIC
EIF
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HMT
HVGLF
HZ~
IHE
J1W
K-O
KOM
L7B
M34
M41
MO0
N9A
NPM
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SPT
SSH
SSP
SSZ
T5K
TEORI
WUQ
Y6R
ZGI
ZXP
~G-
7X8
AAYWO
ACVFH
ADCNI
AEUPX
AFPUW
AGCQF
AGRNS
AIIUN
AKBMS
AKYEP
7S9
EFKBS
L.6
ID FETCH-LOGICAL-p244t-a43fa80287f7ab54634e44e449e21cc7ac6ab90a29ba03f3705fd5999c2e5073
ISSN 1879-016X
0163-7258
IngestDate Sun Aug 24 04:04:27 EDT 2025
Fri Jul 11 14:18:48 EDT 2025
Thu Apr 03 06:56:49 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License Copyright © 2013 Elsevier Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-p244t-a43fa80287f7ab54634e44e449e21cc7ac6ab90a29ba03f3705fd5999c2e5073
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 23563277
PQID 1372079764
PQPubID 23479
PageCount 33
ParticipantIDs proquest_miscellaneous_1733527928
proquest_miscellaneous_1372079764
pubmed_primary_23563277
PublicationCentury 2000
PublicationDate 2013-Aug
20130801
PublicationDateYYYYMMDD 2013-08-01
PublicationDate_xml – month: 08
  year: 2013
  text: 2013-Aug
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Pharmacology & therapeutics (Oxford)
PublicationTitleAlternate Pharmacol Ther
PublicationYear 2013
SSID ssj0004402
Score 2.4917457
SecondaryResourceType review_article
Snippet Medicinal mushrooms have attracted much attention recently owing to their potent therapeutic activity, especially as chemopreventive and immunomodulatory...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 124
SubjectTerms Animals
anti-inflammatory activity
Anti-Inflammatory Agents - pharmacology
Antineoplastic Agents - pharmacology
Antrodia - chemistry
Antrodia - physiology
chemoprevention
Cinnamomum
Complex Mixtures - pharmacology
cytotoxicity
food intoxication
hepatitis
Humans
hypertension
liver
medicinal fungi
molecular cloning
mushrooms
neoplasms
Phylogeny
Protective Agents - pharmacology
quality control
research and development
secondary metabolites
Taiwanofungus camphoratus
traditional medicine
Title Recent research and development of Antrodia cinnamomea
URI https://www.ncbi.nlm.nih.gov/pubmed/23563277
https://www.proquest.com/docview/1372079764
https://www.proquest.com/docview/1733527928
Volume 139
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5a99JLSV95tWULJZd6jbW78mqPpTiEYqeBKOCexGq9wglYMq19SA757ZnZlSqVusUtGGEWW6_vYzQzmpmPkA_c5NwVSrAocTGTEPcwPXSWRUpop60rIq91OD0fnV3JL7N41qqi-u6SdT6wd1v7Sv4HVVgDXLFL9h-Q_blTWIDvgC9sAWHY7oQx-Hz4Kr8e2BN61OZtFZD3MrESHTjw0V6XpVlWS2e6_uhFO7k6lM50-rF8PjY0FHbyBZONz6G6a4bS223pB7tcmLsgWz2tFmZZN02hvff_SMGqsG_Ng9K7zt78wwruqZt9QCWIpMk-BIOZKKy38mqE8DzZstZY2TCzqKYT79jMKDRR_2bLQ1rhZrDCO-GvHivxhJ9MW5_CL-Ozz79mp1eTSZaOZ-lj8oRD3ICSFoP7tuZHylCE2pxgXdoVCv62H-fPkYf3QNI98qwOHeinwIPn5JErX5CTGsHbPk070PXpCe1i-5KMAlloQxYKZKEdstCqoA1ZaEuWVyQ9Haefz1gtmsFW4KmtmZGiMAl4japQJkexA-kkfrTjkbXK2JHJ9dBwnZuhKIQaxsU8hjDBcgexgXhNemVVugNCOYdoIi94ElkckjhPjI7lHMJ_7iDI0faQvG_uTAY2CV80mdJVmx9ZhNJHChxd-ZffKOz2U5onh2Q_3NZsFQasZFzEIwH4He1whGPytOXlG9Jbf9-4t-AnrvN3HvsHsStn1Q
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recent+research+and+development+of+Antrodia+cinnamomea&rft.jtitle=Pharmacology+%26+therapeutics+%28Oxford%29&rft.au=Lu%2C+Mei-Chin&rft.au=El-Shazly%2C+Mohamed&rft.au=Wu%2C+Tung-Ying&rft.au=Du%2C+Ying-Chi&rft.date=2013-08-01&rft.issn=1879-016X&rft.eissn=1879-016X&rft.volume=139&rft.issue=2&rft.spage=124&rft_id=info:doi/10.1016%2Fj.pharmthera.2013.04.001&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1879-016X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1879-016X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1879-016X&client=summon